Synapse - Works

Results (77)

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Journal Article

Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Germline drivers of gynecologic carcinosarcoma

Meeting Abstract

Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Pembrolizumab versus placebo in addition to carboplatin and paclitaxel for measurable stage 3 or 4a, stage 4b or recurrent endometrial cancer: The phase 3, NRG GY018 study

Meeting Abstract

Eskander, R.; Sill, M.; Beffa, L.; Moore, R.; Hope, J.; Musa, F.; Mannel, R.; Shahin, M.; Cantuaria, G.; Girda, E.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Evolution of peripheral and tumor immune parameters as biomarkers of differential sequencing of immune checkpoint blockade and chemoradiotherapy in locally advanced cervical cancer: An NRG Oncology/GOG Study

Meeting Abstract

Zamarin, D.; Deng, W.; Lankes, H.; Ghamande, S.; Holman, L.; Mathews, C.; Park, K.; Banbury, B.; Sherry, N.; Kim, H.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement

Review

Girda, E.; Randall, L. M.; Chino, F.; Monk, B. J.; Farley, J. H.; O'Cearbhaill, R. E.
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: Results of a phase II study (MOONSTONE/GOG-3032)

Journal Article

Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; Gaillard, S.; Adams, S.; Duska, L. R.; Dalton, H.; Holloway, R. W.; Huang, M.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Use of romiplostim in chemotherapy-induced thrombocytopenia in gynecologic and breast cancers

Meeting Abstract

Moufarrij, S.; O'Cearbhaill, R.; Zhou, Q.; Iasonos, A.; Mantha, S.; Wilkins, C.
Gynecologic Oncology (2023)

Fulltext@MSK | Save

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG Oncology/Gynecologic Oncology Group study 0283

Journal Article

O'Cearbhaill, R. E.; Miller, A.; Soslow, R. A.; Lankes, H. A.; DeLair, D.; Segura, S.; Chavan, S.; Zamarin, D.; DeBernardo, R.; Moore, K.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)

Guidelines

Pothuri, B.; Blank, S. V.; Myers, T. K.; Hines, J. F.; Randall, L. M.; O'Cearbhaill, R. E.; Slomovitz, B. M.; Eskander, R. N.; Alvarez Secord, A.; Coleman, R. L.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Carboplatin dosing in the treatment of ovarian cancer: An NRG Oncology group study

Journal Article

Praiss, A. M.; Miller, A.; Smith, J.; Lichtman, S. M.; Bookman, M.; Aghajanian, C.; Sabbatini, P.; Backes, F.; Cohn, D. E.; Argenta, P.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save